Scientific article

HIV and antiretroviral therapy-related fat alterations

Published inNature Reviews. Disease Primers, vol. 6, no. 1, 48
Publication date2020

Early in the HIV epidemic, lipodystrophy, characterized by subcutaneous fat loss (lipoatrophy), with or without central fat accumulation (lipohypertrophy), was recognized as a frequent condition among people living with HIV (PLWH) receiving combination antiretroviral therapy. The subsequent identification of thymidine analogue nucleoside reverse transcriptase inhibitors as the cause of lipoatrophy led to the development of newer antiretroviral agents; however, studies have demonstrated continued abnormalities in fat and/or lipid storage in PLWH treated with newer drugs (including integrase inhibitor-based regimens), with fat gain due to restoration to health in antiretroviral therapy-naive PLWH, which is compounded by the rising rates of obesity. The mechanisms of fat alterations in PLWH are complex, multifactorial and not fully understood, although they are known to result in part from the direct effects of HIV proteins and antiretroviral agents on adipocyte health, genetic factors, increased microbial translocation, changes in the adaptive immune milieu after infection, increased tissue inflammation and accelerated fibrosis. Management includes classical lifestyle alterations with a role for pharmacological therapies and surgery in some patients. Continued fat alterations in PLWH will have an important effect on lifespan, healthspan and quality of life as patients age worldwide, highlighting the need to investigate the critical uncertainties regarding pathophysiology, risk factors and management.

  • Corneal Dystrophies, Hereditary/diagnosis
  • Corneal Dystrophies, Hereditary/physiopathology
  • Corneal Dystrophies, Hereditary/therapy
  • Disease Management
  • Humans
  • Mass Screening/methods
  • Slit Lamp Microscopy/methods
Research group
Citation (ISO format)
KOETHE, John R. et al. HIV and antiretroviral therapy-related fat alterations. In: Nature Reviews. Disease Primers, 2020, vol. 6, n° 1, p. 48. doi: 10.1038/s41572-020-0181-1
Main files (1)
Article (Published version)
Updates (1)
ISSN of the journal2056-676X

Technical informations

Creation10/30/2020 8:18:00 PM
First validation10/30/2020 8:18:00 PM
Update time03/16/2023 12:55:15 AM
Status update03/16/2023 12:55:14 AM
Last indexation05/06/2024 7:49:17 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack